Results 31 to 40 of about 6,974,500 (303)

Severe sinus bradycardia associated with favipiravir in a COVID‐19 patient

Clinical Case Reports, 2021
The antiviral medication “favipiravir” should be considered as a possible cause of unexplained sinus bradycardia.
Mhd Baraa Habib, Mohamed Elshafei, Alaa Rahhal, Mouhand F. H. Mohamed   +3 more
doaj   +1 more source

Impact of untreated diabetes and COVID-19-related diabetes on severe COVID-19

Heliyon, 2022
Diabetes is a common comorbidity in patients with coronavirus disease (COVID-19) and contributes significantly to COVID-19 severity. We aimed to investigate the association between diabetic status and severe COVID-19.
Emi Ushigome, Masahide Hamaguchi, Kazuki Sudo, Nobuko Kitagawa, Yuriko Kondo, Dan Imai, Tomohito Hattori, Takaaki Matsui, Masahiro Yamazaki, Teiji Sawa, Michiaki Fukui   +10 more
doaj   +1 more source

Beating severe covid-19

New Scientist, 2020
We are beginning to understand how the virus kills - and how to stop it.
openaire   +2 more sources

Nigeria: The impact of COVID-19 and food system responses

, 2021
As Nigeria continues to face the effects of the COVID-19 pandemic, CGIAR and partners have expanded access to quality seeds and improved crop varieties, strengthened capacity of women and youth, and informed national responses and policies with evidence ...
COVID-19 Hub
core   +1 more source

Myanmar: The impact of COVID-19 and food system responses

, 2021
In Myanmar, the COVID-19 pandemic and political upheaval have both had significant economic and social repercussions. CGIAR has been working with partners in the country to assess the economic impacts of the pandemic and their consequences for agrifood ...
COVID-19 Hub
core   +1 more source

A case of non‐severe COVID‐19 complicated by pulmonary embolism

Respirology Case Reports, 2020
Novel coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID‐19 is pneumonia, which can progress to acute respiratory distress syndrome and ...
Yuto Akiyama, Kohei Horiuchi, Yasushi Kondo, Hiroki Kabata, Makoto Ishii, Koichi Fukunaga   +5 more
doaj   +1 more source

Ethiopia: The impact of COVID-19 and food system responses

, 2021
In Ethiopia, the COVID-19 pandemic has affected livelihoods and caused declines in the gross domestic product (GDP) of the agrifood system (AFS) as well as in total GDP.
COVID-19 Hub
core   +1 more source

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

, 2021
BACKGROUND: Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may attenuate the inflammatory response in Covid-19. METHODS: We performed an adaptive, phase 2/3, randomized, double-blind, placebo-controlled trial of intravenous sarilumab 200 ...
DiCioccio, A. Thomas, Saggar, Suraj, Sivapalasingam, Sumathi, Aberg, Judith A., Kampman, Wendy, Ferreira, Manuel A., Kosmicki, Jack A., Parrino, Jani, Boyapati, Anita, Criner, Gerard, Hosain, Romana, Labriola-Tompkins, Emily, Akinlade, Bolanle, Brown, Samuel M., Weinreich, David M., Bhore, Rafia, Ng Gong, Michelle, Horowitz, Julie E., Hajizadeh, Negin, Sobieszczyk, Magdalena E., Park, William, Gulabani, Daya, Yancopoulos, George D., Mahmood, Adnan, Lederer, David J., Sperber, Steven J., Musser, Bret, Stein, David K., Baras, Aris, Giannelou, Angeliki, Menon, Vidya, Somersan-Karakaya, Selin, O’Brien, Meagan, Purcell, Lisa A., Nivens, Michael C., Herman, Gary, Kowal, Bari, Waldron, Alpana, Braunstein, Ned, Ramesh, Divya   +39 more
core   +1 more source

Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange

Clinical Case Reports, 2020
Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation.
Fahad Faqihi, Abdulrahman Alharthy, Ziad A. Memish, Demetrios J. Kutsogiannis, Peter G. Brindley, Dimitrios Karakitsos   +5 more
doaj   +1 more source

Severe Thrombocytopenia in a Patient with COVID-19

Infection & Chemotherapy, 2020
Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet, empirical antibacterial agents are frequently combined for the treatment of COVID-19 in addition to antiviral agents, concerning co-existing bacterial pathogens.
Eliel Nham, Jae-Hoon Ko, Byeong-Ho Jeong, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck   +7 more
openaire   +2 more sources